The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Genetic association studies are viewed as problematic and plagued by irreproducibility. Many associations have been reported for type 2 diabetes, but none have been confirmed in multiple samples and with comprehensive controls. We evaluated 16 published genetic associations to type 2 diabetes and related sub-phenotypes using a family-based design to control for population stratification, and replication samples to increase power. We were able to confirm only one association, that of the common Pro12Ala polymorphism in peroxisome proliferator-activated receptor-gamma(PPARgamma) with type 2 diabetes. By analysing over 3,000 individuals, we found a modest (1.25-fold) but significant (P=0.002) increase in diabetes risk associated with the more common proline allele (85% frequency). Moreover, our results resolve a controversy about common variation in PPARgamma. An initial study found a threefold effect, but four of five subsequent publications failed to confirm the association. All six studies are consistent with the odds ratio we describe. The data implicate inherited variation in PPARgamma in the pathogenesis of type 2 diabetes. Because the risk allele occurs at such high frequency, its modest effect translates into a large population attributable risk-influencing as much as 25% of type 2 diabetes in the general population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The other known T2D susceptibility variants were detected with effect sizes consistent with previous reports (2, 3).”
From Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes (2007) · cites this paper as [2]
In the citing paper
“unequivocal replications are so far limited to variants in just three genes: PPARG, KCNJ11 and TCF7L2 (2-4).”
From Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes (2007) · cites this paper as [2]
In the citing paper
“Whereas an initial positive report (61) had not been confirmed in four modest-sized replication studies, larger studies produced strong and consistent evidence of increased risk by a factor of 1.2 (62, 63). The negative studies were actually consistent with the level of increased risk, but simply lacked adequate power to detect it.”
From Genetic Mapping in Human Disease (2008) · cites this paper as [62]
Citations
Cites
Spielman, R. S., McGinnis, R. E., & Ewens, W. J. (1993) · PubMed · Cited by 3,651
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,529
Barroso, I., Gurnell, M., Crowley, V. E. F., Agostini, M., Schwabe, J. W., Soos, M. A., Maslen, G. L., Williams, T. D. M., Lewis, H., Schafer, A. J., et al. (1999) · Nature · doi:10.1038/47254 · Cited by 1,368 · cited 1×
“Third, although much can be learned from rare genetic variants (such as seven patients carrying rare amino acid changes in PPARγ; ref”
BackgroundDeeb, S. S., Fajas, L., Nemoto, M., Pihlajamäki, J., Mykkänen, L., Kuusisto, J., Laakso, M., Fujimoto, W., & Auwerx, J. (1998) · Nature Genetics · doi:10.1038/3099 · Cited by 1,319
Cloning of the β Cell High-Affinity Sulfonylurea Receptor: a Regulator of Insulin Secretion
Aguilar-Bryan, L., Nichols, C. G., Wechsler, S. W., Clement, J. P., Boyd, A. E., González, G., Herrera-Sosa, H., Nguy, K., Bryan, J., & Nelson, D. A. (1995) · Science · doi:10.1126/science.7716547 · Cited by 1,315
A Sibship Test for Linkage in the Presence of Association: The Sib Transmission/Disequilibrium Test
Spielman, R. S., & Ewens, W. J. (1998) · The American Journal of Human Genetics · doi:10.1086/301714 · Cited by 659
Edelstein, S. L., Knowler, W. C., Bain, R. P., Andres, R., Barrett-Connor, E. L., Dowse, G. K., Haffher, S. M., Pettitt, D. J., Sorkin, J. D., Muller, D. C., et al. (1997) · Diabetes · doi:10.2337/diab.46.4.701 · Cited by 641
Obesity Associated with a Mutation in a Genetic Regulator of Adipocyte Differentiation
Ristow, M., Müller-Wieland, D., Pfeiffer, A., Krone, W., & Kahn, C. R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810013391403 · Cited by 545
Widén, E., Lehto, M., Kanninen, T., Walston, J., Shuldiner, A. R., & Groop, L. C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508103330604 · Cited by 541
Self-citation
Cited by
Items 101–200 of 1,003
The Emerging Genetic Architecture of Type 2 Diabetes
Doria, A., Patti, M.-E., & Kahn, C. R. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.08.006 · Cited by 305
Wiltshire, S., Hattersley, A. T., Hitman, G. A., Walker, M., Levy, J. C., Sampson, M., O’Rahilly, S., Frayling, T. M., Bell, J. I., Lathrop, G. M., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/323249 · Cited by 305
Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls
Platform, B. G., Flannick, J., DiscovEHR Collaboration, CHARGE, LuCamp, ProDiGY, GoT2D, ESP, SIGMA-T2D, T2D-GENES, et al. (2019) · Nature · doi:10.1038/s41586-019-1231-2 · Cited by 304
Molecular mechanisms of insulin resistance and associated diseases
Mlinar, B., Marc, J., Janež, A., & Pfeifer, M. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.07.005 · Cited by 301
Ling, C., Poulsen, P., Carlsson, E., Ridderstråle, M., Almgren, P., Wojtaszewski, J., Beck-Nielsen, H., Groop, L., & Vaag, A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21889 · Cited by 300
Self-citationLango, H., the U.K. Type 2 Diabetes Genetics Consortium, Palmer, C. N. A., Morris, A. D., Zeggini, E., Hattersley, A. T., McCarthy, M. I., Frayling, T. M., & Weedon, M. N. (2008) · Diabetes · doi:10.2337/db08-0504 · Cited by 294
Ek, J., Andersen, G., Urhammer, S. A., Gæde, P. H., Drivsholm, T., Borch-Johnsen, K., Hansen, T., & Pedersen, O. (2001) · Diabetologia · doi:10.1007/s001250100032 · Cited by 293
Neve, B., Fernandez-Zapico, M. E., Ashkenazi-Katalan, V., Dina, C., Hamid, Y. H., Joly, E., Vaillant, E., Benmezroua, Y., Durand, E., Bakaher, N., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409177102 · Cited by 293
Florez, J. C. (2008) · Diabetologia · doi:10.1007/s00125-008-1025-9 · Cited by 293
Toxicology and risk assessment of coumarin: Focus on human data
Abraham, K., Wöhrlin, F., Lindtner, O., Heinemeyer, G., & Lampen, A. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900281 · Cited by 292
Nielsen, E.-M. D., Hansen, L., Carstensen, B., Echwald, S. M., Drivsholm, T., Glümer, C., Thorsteinsson, B., Borch-Johnsen, K., Hansen, T., & Pedersen, O. (2003) · Diabetes · doi:10.2337/diabetes.52.2.573 · Cited by 288
Sanghera, D. K., Ortega, L., Han, S., Singh, J., Ralhan, S. K., Wander, G. S., Mehra, N. K., Mulvihill, J. J., Ferrell, R. E., Nath, S. K., et al. (2008) · BMC Medical Genetics · doi:10.1186/1471-2350-9-59 · Cited by 285
Larsen, T. M., Toubro, S., & Astrup, A. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.802223 · Cited by 282
Omori, S., Tanaka, Y., Takahashi, A., Hirose, H., Kashiwagi, A., Kaku, K., Kawamori, R., Nakamura, Y., & Maeda, S. (2008) · Diabetes · doi:10.2337/db07-0979 · Cited by 280
Selective disruption of PPARγ2 impairs the development of adipose tissue and insulin sensitivity
Zhang, J., Fu, M., Cui, T., Xiong, C., Xu, K., Zhong, W., Xiao, Y., Floyd, D., Liang, J., Li, E., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403652101 · Cited by 279
Chandak, G. R., Janipalli, C. S., Bhaskar, S., Kulkarni, S. R., Mohankrishna, P., Hattersley, A. T., Frayling, T. M., & Yajnik, C. S. (2006) · Diabetologia · doi:10.1007/s00125-006-0502-2 · Cited by 279
Genetic epidemiology of diabetes
Permutt, M. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24758 · Cited by 277
Gene-environment interaction and obesity: Nutrition Reviews©, Vol. 66, No. 12
Qi, L., & Cho, Y. A. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2008.00128.x · Cited by 275
A Unique PPARγ Ligand with Potent Insulin-Sensitizing yet Weak Adipogenic Activity
Rocchi, S., Picard, F., Vamecq, J., Gelman, L., Potier, N., Zeyer, D., Dubuquoy, L., Bac, P., Champy, M.-F., Plunket, K. D., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00353-7 · Cited by 272
Large-Scale Gene-Centric Meta-Analysis across 39 Studies Identifies Type 2 Diabetes Loci
Saxena, R., Elbers, C. C., Guo, Y., Peter, I., Gaunt, T. R., Mega, J. L., Lanktree, M. B., Tare, A., Castillo, B. A., Li, Y. R., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.12.022 · Cited by 270
Self-citationTaylor, K. D., Norris, J. M., & Rotter, J. I. (2007) · Diabetes · doi:10.2337/db07-1324 · Cited by 269
Combining Information from Common Type 2 Diabetes Risk Polymorphisms Improves Disease Prediction
Weedon, M. N., McCarthy, M. I., Hitman, G., Walker, M., Groves, C. J., Zeggini, E., Rayner, N. W., Shields, B., Owen, K. R., Hattersley, A. T., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030374 · Cited by 268
Barroso, I. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01550.x · Cited by 268
Silander, K., Mohlke, K. L., Scott, L. J., Peck, E. C., Hollstein, P., Skol, A. D., Jackson, A. U., Deloukas, P., Hunt, S., Stavrides, G., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.4.1141 · Cited by 267
Francke, S. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.24.2751 · Cited by 265
PPARG F388L, a Transactivation-Deficient Mutant, in Familial Partial Lipodystrophy
Hegele, R. A., Cao, H., Frankowski, C., Mathews, S. T., & Leff, T. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3586 · Cited by 264
Hafler, D. A., Slavik, J. M., Anderson, D. E., O'Connor, K. C., De Jager, P., & Baecher‐Allan, C. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00240.x · Cited by 260
Knouff, C., & Auwerx, J. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0036 · Cited by 256
Type 2 diabetes: new genes, new understanding
Prokopenko, I., McCarthy, M. I., & Lindgren, C. M. (2008) · Trends in Genetics · doi:10.1016/j.tig.2008.09.004 · Cited by 254
Self-citationFærch, K., Borch-Johnsen, K., Holst, J. J., & Vaag, A. (2009) · Diabetologia · doi:10.1007/s00125-009-1443-3 · Cited by 252
Genetic Factors in Type 2 Diabetes: The End of the Beginning?
O'Rahilly, S., Barroso, I., & Wareham, N. J. (2005) · Science · doi:10.1126/science.1104346 · Cited by 252
Groves, C. J., Zeggini, E., Minton, J., Frayling, T. M., Weedon, M. N., Rayner, N. W., Hitman, G. A., Walker, M., Wiltshire, S., Hattersley, A. T., et al. (2006) · Diabetes · doi:10.2337/db06-0355 · Cited by 252
Coviello, A. D., Haring, R., Wellons, M., Vaidya, D., Lehtimäki, T., Keildson, S., Lunetta, K. L., He, C., Fornage, M., Lagou, V., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002805 · Cited by 250
Schwanstecher, C., Meyer, U., & Schwanstecher, M. (2002) · Diabetes · doi:10.2337/diabetes.51.3.875 · Cited by 243
Mori, H., Ikegami, H., Kawaguchi, Y., Seino, S., Yokoi, N., Takeda, J., Inoue, I., Seino, Y., Yasuda, K., Hanafusa, T., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.4.891 · Cited by 238
Scott, L. J., Bonnycastle, L. L., Willer, C. J., Sprau, A. G., Jackson, A. U., Narisu, N., Duren, W. L., Chines, P. S., Stringham, H. M., Erdos, M. R., et al. (2006) · Diabetes · doi:10.2337/db06-0341 · Cited by 236
Groop, L., & Orho‐Melander, M. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00864.x · Cited by 234
Self-citationGenome-wide association studies in type 2 diabetes
McCarthy, M. I., & Zeggini, E. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0027-4 · Cited by 233
Peroxisome proliferator-activated receptor gamma (PPARγ) and its ligands: A review
Houseknecht, K. L., Cole, B. M., & Steele, P. J. (2002) · Domestic Animal Endocrinology · doi:10.1016/s0739-7240(01)00117-5 · Cited by 232
Race, Ancestry, and Genes: Implications for Defining Disease Risk
Kittles, R. A., & Weiss, K. M. (2003) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.4.070802.110356 · Cited by 232
Osawa, H., Yamada, K., Onuma, H., Murakami, A., Ochi, M., Kawata, H., Nishimiya, T., Niiya, T., Shimizu, I., Nishida, W., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/424761 · Cited by 229
Prospective functional classification of all possible missense variants in PPARG
UK Monogenic Diabetes Consortium, Majithia, A. R., Myocardial Infarction Genetics Consortium, UK Congenital Lipodystrophy Consortium, Tsuda, B., Agostini, M., Gnanapradeepan, K., Rice, R., Peloso, G., Patel, K. A., et al. (2016) · Nature Genetics · doi:10.1038/ng.3700 · Cited by 227
Self-citationCommon Type 2 Diabetes Risk Gene Variants Associate with Gestational Diabetes
Lauenborg, J., Grarup, N., Damm, P., Borch-Johnsen, K., Jørgensen, T., Pedersen, O., & Hansen, T. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1336 · Cited by 227
Gerich, J. E. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.4.447 · Cited by 222
Testing for Population Subdivision and Association in Four Case-Control Studies
Ardlie, K. G., Lunetta, K. L., & Seielstad, M. (2002) · The American Journal of Human Genetics · doi:10.1086/341719 · Cited by 222
PPARγ in human and mouse physiology
HEIKKINEN, S., AUWERX, J., & ARGMANN, C. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.03.006 · Cited by 221
Eriksson, J. G., Lindi, V., Uusitupa, M., Forsén, T. J., Laakso, M., Osmond, C., & Barker, D. J. P. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2321 · Cited by 220
The Genetic Landscape of Type 2 Diabetes in Mice
Clee, S. M., & Attie, A. D. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0035 · Cited by 220
An evolutionary framework for common diseases: the ancestral-susceptibility model
Di Rienzo, A., & Hudson, R. R. (2005) · Trends in Genetics · doi:10.1016/j.tig.2005.08.007 · Cited by 218
Craddock, N., Owen, M. J., & O'Donovan, M. C. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001808 · Cited by 216
The Epigenetic Basis of Twin Discordance in Age-Related Diseases
Poulsen, P., Esteller, M., Vaag, A., & Fraga, M. F. (2007) · Pediatric Research · doi:10.1203/pdr.0b013e31803c7b98 · Cited by 213
The genetic and epigenetic basis of type 2 diabetes and obesity
Drong, A. W., Lindgren, C. M., & McCarthy, M. I. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.149 · Cited by 212
Self-citationPeroxisome proliferator-activated receptors: from transcriptional control to clinical practice
Torra, I. P., Chinetti, G., Duval, C., Fruchart, J.-C., & Staels, B. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200106000-00002 · Cited by 210
Adachi, M., Kurotani, R., Morimura, K., Shah, Y., Sanford, M., Madison, B. B., Gumucio, D. L., Marin, H. E., Peters, J. M., Young, H. A., et al. (2006) · Gut · doi:10.1136/gut.2005.081745 · Cited by 209
Campa, D. (2003) · Carcinogenesis · doi:10.1093/carcin/bgh008 · Cited by 209
Introduction to Genetic Association Studies
Lewis, C. M., & Knight, J. (2012) · Cold Spring Harbor Protocols · doi:10.1101/pdb.top068163 · Cited by 208
Gouda, H. N., Sagoo, G. S., Harding, A.-H., Yates, J., Sandhu, M. S., & Higgins, J. P. T. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwp450 · Cited by 208
Masud, S., & Ye, S. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.10.773 · Cited by 205
The Metabolic Syndrome in Men study: a resource for studies of metabolic and cardiovascular diseases
Laakso, M., Kuusisto, J., Stančáková, A., Kuulasmaa, T., Pajukanta, P., Lusis, A. J., Collins, F. S., Mohlke, K. L., & Boehnke, M. (2017) · Journal of Lipid Research · doi:10.1194/jlr.o072629 · Cited by 204
Zhang, C., Qi, L., Hunter, D. J., Meigs, J. B., Manson, J. E., van Dam, R. M., & Hu, F. B. (2006) · Diabetes · doi:10.2337/db06-0643 · Cited by 204
Winckler, W., Weedon, M. N., Graham, R. R., McCarroll, S. A., Purcell, S., Almgren, P., Tuomi, T., Gaudet, D., Boström, K. B., Walker, M., et al. (2007) · Diabetes · doi:10.2337/db06-0202 · Cited by 203
Self-citationLocalization of a Susceptibility Gene for Type 2 Diabetes to Chromosome 5q34–q35.2
Reynisdottir, I., Thorleifsson, G., Benediktsson, R., Sigurdsson, G., Emilsson, V., Einarsdottir, A. S., Hjorleifsdottir, E. E., Orlygsdottir, G. T., Bjornsdottir, G. T., Saemundsdottir, J., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/377139 · Cited by 198
Type 2 Diabetes Whole-Genome Association Study in Four Populations: The DiaGen Consortium
Salonen, J. T., Uimari, P., Aalto, J.-M., Pirskanen, M., Kaikkonen, J., Todorova, B., Hyppönen, J., Korhonen, V.-P., Asikainen, J., Devine, C., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/520599 · Cited by 196
Genetic Basis of Atherosclerosis: Part I: New Genes and Pathways
Lusis, A. J., Fogelman, A. M., & Fonarow, G. C. (2004) · Circulation · doi:10.1161/01.cir.0000143041.58692.cc · Cited by 196
Molecular Mechanism of Insulin Resistance and Obesity
Kadowaki, T., Hara, K., Yamauchi, T., Terauchi, Y., Tobe, K., & Nagai, R. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322801003 · Cited by 195
Lindi, V. I., Uusitupa, M. I. J., Lindström, J., Louheranta, A., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2581 · Cited by 195
Attempted Replication of Reported Chronic Obstructive Pulmonary Disease Candidate Gene Associations
Hersh, C. P., DeMeo, D. L., Lange, C., Litonjua, A. A., Reilly, J. J., Kwiatkowski, D., Laird, N., Sylvia, J. S., Sparrow, D., Speizer, F. E., et al. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0073oc · Cited by 193
Waters, K. M., Stram, D. O., Hassanein, M. T., Le Marchand, L., Wilkens, L. R., Maskarinec, G., Monroe, K. R., Kolonel, L. N., Altshuler, D., Henderson, B. E., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001078 · Cited by 191
Self-citationChang, Y.-C., Chang, T.-J., Jiang, Y.-D., Kuo, S.-S., Lee, K.-C., Chiu, K. C., & Chuang, L.-M. (2007) · Diabetes · doi:10.2337/db07-0421 · Cited by 191
Robitaille, J., Després, J., Pérusse, L., & Vohl, M. (2003) · Clinical Genetics · doi:10.1034/j.1399-0004.2003.00026.x · Cited by 190
Self-citationLing, C., Poulsen, P., Simonsson, S., Rönn, T., Holmkvist, J., Almgren, P., Hagert, P., Nilsson, E., Mabey, A. G., Nilsson, P., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30938 · Cited by 189
Self-citationGenetics of diabetes – Are we missing the genes or the disease?
Groop, L., & Pociot, F. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.04.002 · Cited by 188
Self-citationMeigs, J. B., Panhuysen, C. I. M., Myers, R. H., Wilson, P. W. F., & Cupples, L. A. (2002) · Diabetes · doi:10.2337/diabetes.51.3.833 · Cited by 185
The genetics of the polycystic ovary syndrome
Urbanek, M. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0400 · Cited by 185
Chauhan, G., Spurgeon, C. J., Tabassum, R., Bhaskar, S., Kulkarni, S. R., Mahajan, A., Chavali, S., Kumar, M. V. K., Prakash, S., Dwivedi, O. P., et al. (2010) · Diabetes · doi:10.2337/db09-1386 · Cited by 185
Weedon, M. N., Schwarz, P. E. H., Horikawa, Y., Iwasaki, N., Illig, T., Holle, R., Rathmann, W., Selisko, T., Schulze, J., Owen, K. R., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/379285 · Cited by 184
Evans, J. C., Frayling, T. M., Cassell, P. G., Saker, P. J., Hitman, G. A., Walker, M., Levy, J. C., O’Rahilly, S., Rao, P. V. S., Bennett, A. J., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/323315 · Cited by 183
A Central Role for GRB10 in Regulation of Islet Function in Man
Prokopenko, I., Poon, W., Mägi, R., Prasad B, R., Salehi, S. A., Almgren, P., Osmark, P., Bouatia-Naji, N., Wierup, N., Fall, T., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004235 · Cited by 183
Self-citationManning, A. K., LaValley, M., Liu, C.-T., Rice, K., An, P., Liu, Y., Miljkovic, I., Rasmussen-Torvik, L., Harris, T. B., Province, M. A., et al. (2011) · Genetic Epidemiology · doi:10.1002/gepi.20546 · Cited by 183
Assessing the Shape of the Glucose Curve During an Oral Glucose Tolerance Test
Tschritter, O., Fritsche, A., Shirkavand, F., Machicao, F., Häring, H., & Stumvoll, M. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1026 · Cited by 182
SNP association studies in Alzheimer's disease highlight problems for complex disease analysis
Emahazion, T. (2001) · Trends in Genetics · doi:10.1016/s0168-9525(01)02342-3 · Cited by 182
Non-DNA binding, dominant-negative, human PPARγ mutations cause lipodystrophic insulin resistance
Agostini, M., Schoenmakers, E., Mitchell, C., Szatmari, I., Savage, D., Smith, A., Rajanayagam, O., Semple, R., Luan, J., Bath, L., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.09.003 · Cited by 182
Once and Again—Issues Surrounding Replication in Genetic Association Studies
Hirschhorn, J. N., & Altshuler, D. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021329 · Cited by 181
Self-citationNebert, D. W., Zhang, G., & Vesell, E. S. (2008) · Drug Metabolism Reviews · doi:10.1080/03602530801952864 · Cited by 181
Fat poetry: a kingdom for PPARγ
Anghel, S. I., & Wahli, W. (2007) · Cell Research · doi:10.1038/cr.2007.48 · Cited by 180
The Metabolic Syndrome: Peroxisome Proliferator-Activated Receptor γ and Its Therapeutic Modulation
Gurnell, M., Savage, D. B., Chatterjee, V. K. K., & O’Rahilly, S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030435 · Cited by 179
Mouse models for mitochondrial disease
Wallace, D. C. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1393 · Cited by 179
Peroxisome proliferator activated receptors and obesity
Kersten, S. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01431-0 · Cited by 179
Designing candidate gene and genome-wide case–control association studies
Zondervan, K. T., & Cardon, L. R. (2007) · Nature Protocols · doi:10.1038/nprot.2007.366 · Cited by 178
Nutrigenetics and Metabolic Disease: Current Status and Implications for Personalised Nutrition
Phillips, C. (2013) · Nutrients · doi:10.3390/nu5010032 · Cited by 178
Benayed, R., Gharani, N., Rossman, I., Mancuso, V., Lazar, G., Kamdar, S., Bruse, S. E., Tischfield, S., Smith, B. J., Zimmerman, R. A., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/497705 · Cited by 177
Lee, Y.-H., Kang, E. S., Kim, S. H., Han, S. J., Kim, C. H., Kim, H. J., Ahn, C. W., Cha, B. S., Nam, M., Nam, C. M., et al. (2008) · Journal of Human Genetics · doi:10.1007/s10038-008-0341-8 · Cited by 177
Using genetic variation to study human disease
Taylor, J. G., Choi, E.-H., Foster, C. B., & Chanock, S. J. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02183-9 · Cited by 176
The metabolic syndrome: the crossroads of diet and genetics
Roche, H. M., Phillips, C., & Gibney, M. J. (2005) · Proceedings of the Nutrition Society · doi:10.1079/pns2005445 · Cited by 175
Genetics of type 2 diabetes mellitus
Malecki, M. T. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.03.003 · Cited by 175
Loktionov, A. S. (2003) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(03)00032-9 · Cited by 175
The emerging genetics of type 2 diabetes
Bonnefond, A., Froguel, P., & Vaxillaire, M. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.06.004 · Cited by 174
Xia, Q., & Grant, S. F. A. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12020 · Cited by 174
Type 2 diabetes: genetic data sharing to advance complex disease research
Flannick, J. A., & Florez, J. C. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.56 · Cited by 173
Pattern of Sequence Variation Across 213 Environmental Response Genes
Livingston, R. J., von Niederhausern, A., Jegga, A. G., Crawford, D. C., Carlson, C. S., Rieder, M. J., Gowrisankar, S., Aronow, B. J., Weiss, R. B., & Nickerson, D. A. (2004) · Genome Research · doi:10.1101/gr.2730004 · Cited by 173
Metadata
- Authors
- Altshuler, D., Hirschhorn, J. N., Klannemark, M., Lindgren, C. M., Vohl, M.-C., Nemesh, J., Lane, C. R., Schaffner, S. F., Bolk, S., Brewer, C., Tuomi, T., Gaudet, D., Hudson, T. J., Daly, M., Groop, L., & Lander, E. S.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Boston Children's Hospital (US)
- Lund University (SE)
- McGill University Health Centre (CA)
- Hôpital de Chicoutimi (CA)
- Corresponding author
- Lander, Eric S.
- ORCID
- Venue
- Nature Genetics
- Published
- 2000-09
- Volume
- 26
- Issue
- 1
- Pages
- 76-80
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1485161311
- Cited by
- 1,766
- References
- 40
- Citations by year
- 2026: 15 · 2025: 18 · 2024: 11 · 2023: 20 · 2022: 22 · 2021: 28 · 2020: 20 · 2019: 27 · 2018: 32 · 2017: 28 · 2016: 63 · 2015: 37 · 2014: 62 · 2013: 75 · 2012: 75
- FWCI
- 31.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Corpus Université Laval (Université Laval) (submittedVersion)
- Funders
- Wellcome Trust (090532)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
- Keywords
- type 2 diabetes, PPARγ, Pro12Ala polymorphism, genetic association, population stratification, replication, risk alleles, population attributable risk, diabetes pathogenesis
- MeSH terms
- Adult, Aged, Alanine, Alleles, Blood Glucose, Blood Pressure, Cholesterol, Diabetes Mellitus, Type 2, Family Health, Fathers, Female, Genotype, Humans, Lipoproteins, HDL, Male, Middle Aged, Models, Genetic, Mothers, Phenotype, Polymorphism, Genetic, Proline, Risk Factors, Transcription Factors, Linkage Disequilibrium, Body Mass Index, Age of Onset, Receptors, Cytoplasmic and Nuclear
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.